| . | . | Study population (n) . | . | |
|---|---|---|---|---|
| Study . | Age of study participants (years) . | HD . | PD . | Key findings . |
| North Thames Dialysis Study Harris et al. [50] | >70 | 96 | 78 | • No difference in mortality or QoL at 12 months |
| BOLDE study Brown et al. [57] | >65 | 70 | 70 | • QoL not statistically different between HD and PD cohorts • Depression and feelings of illness intrusion significantly less in the PD cohort |
| ERA–EDTA Registry van de Luijtgaarden et al. [54] | Multiple age categories, including 60–69 and >70 | 8347 | 1544 | • Survival better on PD in patients >70 years versus HD • Increasing age associated with a lower likelihood of receiving PD, particularly in females • Non-diabetic patients and those with malignancy less likely to receive PD, despite better survival rates |
| Foote et al. [52] | >75 | 1328 | 453 | • Median survival for the older person starting dialysis was 2.3 years • Mortality risk increased with number of comorbidities and age • Late referral and lack of prepared dialysis access were risk factors for poorer survival |
| Korean meta-analysis Han et al. [55] | >65 | 10 675 | 2390 | • Higher mortality rate in PD cohort compared to HD (P < .001) • Survival benefit of HD in those with diabetes mellitus or dialysis duration >1 year |
| Wolfgram et al. [68] | mean = 69.2 | 112 960 | 8663 | • Lower incidence of dementia in the PD cohort over 3 years • Risk of dementia lower for people starting on PD |
| FEPOD study Iyasere et al. [6] | >60 | 122 | 129 (assisted PD) | • No difference in QoL • Higher treatment satisfaction scores for people on assisted PD compared to those on in-centre HD |
| Swedish Renal Registry Rydell et al. [56] | >65 | 118 | 118 (assisted PD) | • No significant difference in number of days per year in hospital, number of hospitalizations, or discontinuation of dialysis modality between groups • Worse survival on assisted PD, however likely due to use as a palliative treatment • Assisted PD likely to be a reasonable alternative to HD in the frail, older population |
| . | . | Study population (n) . | . | |
|---|---|---|---|---|
| Study . | Age of study participants (years) . | HD . | PD . | Key findings . |
| North Thames Dialysis Study Harris et al. [50] | >70 | 96 | 78 | • No difference in mortality or QoL at 12 months |
| BOLDE study Brown et al. [57] | >65 | 70 | 70 | • QoL not statistically different between HD and PD cohorts • Depression and feelings of illness intrusion significantly less in the PD cohort |
| ERA–EDTA Registry van de Luijtgaarden et al. [54] | Multiple age categories, including 60–69 and >70 | 8347 | 1544 | • Survival better on PD in patients >70 years versus HD • Increasing age associated with a lower likelihood of receiving PD, particularly in females • Non-diabetic patients and those with malignancy less likely to receive PD, despite better survival rates |
| Foote et al. [52] | >75 | 1328 | 453 | • Median survival for the older person starting dialysis was 2.3 years • Mortality risk increased with number of comorbidities and age • Late referral and lack of prepared dialysis access were risk factors for poorer survival |
| Korean meta-analysis Han et al. [55] | >65 | 10 675 | 2390 | • Higher mortality rate in PD cohort compared to HD (P < .001) • Survival benefit of HD in those with diabetes mellitus or dialysis duration >1 year |
| Wolfgram et al. [68] | mean = 69.2 | 112 960 | 8663 | • Lower incidence of dementia in the PD cohort over 3 years • Risk of dementia lower for people starting on PD |
| FEPOD study Iyasere et al. [6] | >60 | 122 | 129 (assisted PD) | • No difference in QoL • Higher treatment satisfaction scores for people on assisted PD compared to those on in-centre HD |
| Swedish Renal Registry Rydell et al. [56] | >65 | 118 | 118 (assisted PD) | • No significant difference in number of days per year in hospital, number of hospitalizations, or discontinuation of dialysis modality between groups • Worse survival on assisted PD, however likely due to use as a palliative treatment • Assisted PD likely to be a reasonable alternative to HD in the frail, older population |
| . | . | Study population (n) . | . | |
|---|---|---|---|---|
| Study . | Age of study participants (years) . | HD . | PD . | Key findings . |
| North Thames Dialysis Study Harris et al. [50] | >70 | 96 | 78 | • No difference in mortality or QoL at 12 months |
| BOLDE study Brown et al. [57] | >65 | 70 | 70 | • QoL not statistically different between HD and PD cohorts • Depression and feelings of illness intrusion significantly less in the PD cohort |
| ERA–EDTA Registry van de Luijtgaarden et al. [54] | Multiple age categories, including 60–69 and >70 | 8347 | 1544 | • Survival better on PD in patients >70 years versus HD • Increasing age associated with a lower likelihood of receiving PD, particularly in females • Non-diabetic patients and those with malignancy less likely to receive PD, despite better survival rates |
| Foote et al. [52] | >75 | 1328 | 453 | • Median survival for the older person starting dialysis was 2.3 years • Mortality risk increased with number of comorbidities and age • Late referral and lack of prepared dialysis access were risk factors for poorer survival |
| Korean meta-analysis Han et al. [55] | >65 | 10 675 | 2390 | • Higher mortality rate in PD cohort compared to HD (P < .001) • Survival benefit of HD in those with diabetes mellitus or dialysis duration >1 year |
| Wolfgram et al. [68] | mean = 69.2 | 112 960 | 8663 | • Lower incidence of dementia in the PD cohort over 3 years • Risk of dementia lower for people starting on PD |
| FEPOD study Iyasere et al. [6] | >60 | 122 | 129 (assisted PD) | • No difference in QoL • Higher treatment satisfaction scores for people on assisted PD compared to those on in-centre HD |
| Swedish Renal Registry Rydell et al. [56] | >65 | 118 | 118 (assisted PD) | • No significant difference in number of days per year in hospital, number of hospitalizations, or discontinuation of dialysis modality between groups • Worse survival on assisted PD, however likely due to use as a palliative treatment • Assisted PD likely to be a reasonable alternative to HD in the frail, older population |
| . | . | Study population (n) . | . | |
|---|---|---|---|---|
| Study . | Age of study participants (years) . | HD . | PD . | Key findings . |
| North Thames Dialysis Study Harris et al. [50] | >70 | 96 | 78 | • No difference in mortality or QoL at 12 months |
| BOLDE study Brown et al. [57] | >65 | 70 | 70 | • QoL not statistically different between HD and PD cohorts • Depression and feelings of illness intrusion significantly less in the PD cohort |
| ERA–EDTA Registry van de Luijtgaarden et al. [54] | Multiple age categories, including 60–69 and >70 | 8347 | 1544 | • Survival better on PD in patients >70 years versus HD • Increasing age associated with a lower likelihood of receiving PD, particularly in females • Non-diabetic patients and those with malignancy less likely to receive PD, despite better survival rates |
| Foote et al. [52] | >75 | 1328 | 453 | • Median survival for the older person starting dialysis was 2.3 years • Mortality risk increased with number of comorbidities and age • Late referral and lack of prepared dialysis access were risk factors for poorer survival |
| Korean meta-analysis Han et al. [55] | >65 | 10 675 | 2390 | • Higher mortality rate in PD cohort compared to HD (P < .001) • Survival benefit of HD in those with diabetes mellitus or dialysis duration >1 year |
| Wolfgram et al. [68] | mean = 69.2 | 112 960 | 8663 | • Lower incidence of dementia in the PD cohort over 3 years • Risk of dementia lower for people starting on PD |
| FEPOD study Iyasere et al. [6] | >60 | 122 | 129 (assisted PD) | • No difference in QoL • Higher treatment satisfaction scores for people on assisted PD compared to those on in-centre HD |
| Swedish Renal Registry Rydell et al. [56] | >65 | 118 | 118 (assisted PD) | • No significant difference in number of days per year in hospital, number of hospitalizations, or discontinuation of dialysis modality between groups • Worse survival on assisted PD, however likely due to use as a palliative treatment • Assisted PD likely to be a reasonable alternative to HD in the frail, older population |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
